Published in J Clin Microbiol on October 01, 2001
Colonization by Pneumocystis jirovecii and its role in disease. Clin Microbiol Rev (2012) 1.68
Early acquisition of Pneumocystis carinii in neonatal rats as evidenced by PCR and oral swabs. Eukaryot Cell (2002) 1.27
Transcriptome of Pneumocystis carinii during fulminate infection: carbohydrate metabolism and the concept of a compatible parasite. PLoS One (2007) 1.20
Microbial antigenic variation mediated by homologous DNA recombination. FEMS Microbiol Rev (2012) 1.18
Genotypes at the internal transcribed spacers of the nuclear rRNA operon of Pneumocystis jiroveci in nonimmunosuppressed infants without severe pneumonia. J Clin Microbiol (2003) 1.06
Diversity at the locus associated with transcription of a variable surface antigen of Pneumocystis carinii as an index of population structure and dynamics in infected rats. Infect Immun (2003) 1.04
Biofilm formation by Pneumocystis spp. Eukaryot Cell (2008) 0.96
Are members of the fungal genus pneumocystis (a) commensals; (b) opportunists; (c) pathogens; or (d) all of the above? PLoS Pathog (2010) 0.91
Pneumocystis murina MSG gene family and the structure of the locus associated with its transcription. Fungal Genet Biol (2007) 0.86
Pneumocystis carinii infection causes lung lesions historically attributed to rat respiratory virus. Comp Med (2011) 0.86
Noninvasive method for monitoring Pneumocystis carinii pneumonia. Emerg Infect Dis (2003) 0.84
Complexity of the MSG gene family of Pneumocystis carinii. BMC Genomics (2009) 0.83
Use of terbinafine in mouse and rat models of Pneumocystis carinii pneumonia. Antimicrob Agents Chemother (2002) 0.82
Pneumocystis murina colonization in immunocompetent surfactant protein A deficient mice following environmental exposure. Respir Res (2009) 0.79
The ecology of pneumocystis: perspectives, personal recollections, and future research opportunities. J Eukaryot Microbiol (2013) 0.78
Chitinases in Pneumocystis carinii pneumonia. Med Microbiol Immunol (2012) 0.78
The state of research for AIDS-associated opportunistic infections and the importance of sustaining smaller research communities. Eukaryot Cell (2011) 0.75
Histopathology of Pneumocystis carinii pneumonia in immunocompetent laboratory rats. Exp Ther Med (2014) 0.75
Detection of Pneumocystis in the nasal swabs of immune-suppressed rats by use of PCR and microscopy. Med Sci Monit Basic Res (2013) 0.75
Latent Pneumocystis infection of rats, relapse, and chemotherapy. Lab Invest (1966) 7.58
Detection of Pneumocystis carinii with DNA amplification. Lancet (1990) 5.50
Natural mode of acquisition for de novo infection with Pneumocystis carinii. J Infect Dis (1982) 2.80
Serologic responses to Pneumocystis carinii antigens in health and disease. J Infect Dis (1990) 2.51
Nude mouse: a new experimental model for Pneumocystis carinii infection. Science (1977) 2.16
Analyses of rat Pneumocystis carinii antigens recognized by human and rat antibodies by using western immunoblotting. Infect Immun (1986) 1.81
Pneumocystis carinii karyotypes. J Clin Microbiol (1990) 1.72
Transmission of Pneumocystis carinii disease from immunocompetent contacts of infected hosts to susceptible hosts. Eur J Clin Microbiol Infect Dis (2000) 1.55
Clusters of Pneumocystis carinii pneumonia: analysis of person-to-person transmission by genotyping. QJM (1998) 1.54
Genetic stability and diversity of Pneumocystis carinii infecting rat colonies. Infect Immun (1993) 1.51
Transmission of Pneumocystis carinii DNA from a patient with P. carinii pneumonia to immunocompetent contact health care workers. J Clin Microbiol (2000) 1.50
A rapid staining procedure for Pneumocystis carinii. Am J Med Technol (1973) 1.48
Sporogony in Pneumocystis carinii: synaptonemal complexes and meiotic nuclear divisions observed in precysts. J Protozool (1984) 1.33
Pneumocystis carinii: immunoblotting and immunofluorescent analyses of serum antibodies during experimental rat infection and recovery. Exp Parasitol (1987) 1.25
Developmental biology of Pneumocystis carinii, and alternative view on the life cycle of the parasite. Z Parasitenkd (1978) 1.04
Search for Pneumocystis carinii DNA in upper and lower respiratory tract of humans. Diagn Microbiol Infect Dis (2000) 1.03
DNA amplification of nasopharyngeal aspirates in rats: a procedure to detect Pneumocystis carinii. Microb Pathog (1999) 1.00
Discrimination of rat-derived Pneumocystis carinii f. sp. Carinii and Pneumocystis carinii f. sp. Ratti using the polymerase chain reaction. Mol Cell Probes (1999) 0.95
Antigenic differences associated with genetically distinct Pneumocystis carinii from rats. Infect Immun (1996) 0.94
Latent Pneumocystis carinii infection in commercial rat colonies: comparison of inductive immunosuppressants plus histopathology, PCR, and serology as detection methods. J Clin Microbiol (1999) 0.92
Letter: Identification of Pneumocystis carinii in sputum. N Engl J Med (1973) 0.80
Detection of Pneumocystis carinii in induced sputa from immunocompromised patients using a repetitive DNA probe. Mol Cell Probes (1997) 0.79
Development of resistance to amphotericin B in Candida lusitaniae infecting a human. Antimicrob Agents Chemother (1979) 3.79
Pneumocystis carinii: sequence from ribosomal RNA implies a close relationship with fungi. Exp Parasitol (1989) 2.06
Growth and serial passage of Pneumocystis carinii in the A549 cell line. Infect Immun (1984) 1.92
The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin. J Immunol (1992) 1.92
Properties of the major antigens of rat and human Pneumocystis carinii. Infect Immun (1989) 1.88
Pneumocystis carinii: growth variables and estimates in the A549 and WI-38 VA13 human cell lines. Exp Parasitol (1985) 1.81
Pneumocystis carinii karyotypes. J Clin Microbiol (1990) 1.72
Method of testing the susceptibility of Pneumocystis carinii to antimicrobial agents in vitro. Antimicrob Agents Chemother (1985) 1.65
Comparison of histologic and quantitative techniques in evaluation of therapy for experimental Pneumocystis carinii pneumonia. Antimicrob Agents Chemother (1987) 1.55
Cationic antitrypanosomal and other antimicrobial agents in the therapy of experimental Pneumocystis carinii pneumonia. Antimicrob Agents Chemother (1988) 1.53
Safety, pharmacokinetics, and functional activity of human anti-Pseudomonas aeruginosa monoclonal antibodies in septic and nonseptic patients. J Infect Dis (1991) 1.50
Molecular genetic distinction of Pneumocystis carinii from rats and humans. J Eukaryot Microbiol (1994) 1.49
Use of DBA/2N mice in models of systemic candidiasis and pulmonary and systemic aspergillosis. Infect Immun (1990) 1.38
Characterisation of an antigenically unusual virus responsible for two outbreaks of Newcastle disease in the Republic of Ireland in 1990. Vet Rec (1992) 1.35
Inhibition by lysozyme of growth of the spherule phase of Coccidioides immitis in vitro. Infect Immun (1974) 1.33
Protective activity of an intravenous immune globulin (human) enriched in antibody against lipopolysaccharide antigens of Pseudomonas aeruginosa. Am J Med (1984) 1.31
Inhibitors of folic acid synthesis in the treatment of experimental Pneumocystis carinii pneumonia. Antimicrob Agents Chemother (1988) 1.30
Pneumocystis carinii: immunoblotting and immunofluorescent analyses of serum antibodies during experimental rat infection and recovery. Exp Parasitol (1987) 1.25
Characterization of viruses which represent further distinct serotypes (PMV-8 and PMV-9) of avian paramyxoviruses. Arch Virol (1983) 1.25
Use of an ATP bioluminescent assay to evaluate viability of Pneumocystis carinii from rats. J Clin Microbiol (1994) 1.23
Inhibition of growth of Coccidioides immitis on Sabouraud medium containing polymyxin B. J Clin Microbiol (1975) 1.22
Lymphocyte changes during chronic administration of and withdrawal from corticosteroids: relation to Pneumocystis carinii pneumonia. J Immunol (1984) 1.20
The ste3 pheromone receptor gene of Pneumocystis carinii is surrounded by a cluster of signal transduction genes. Genetics (2001) 1.19
Molecular epidemiology and antibiotic susceptibility of enterococci in Cincinnati, Ohio: a prospective citywide survey. J Clin Microbiol (1997) 1.19
Comparison of Newcastle disease viruses isolated from cormorants in Canada and the USA in 1975, 1990 and 1992. Can J Vet Res (1996) 1.18
Antigenic diversity and similarities detected in avian paramyxovirus type 1 (Newcastle disease virus) isolates using monoclonal antibodies. Avian Pathol (1997) 1.17
Immunization of mice against coccidioidomycosis with a subcellular vaccine. Infect Immun (1979) 1.16
Effect of amphotericin B and rifampin against Coccidioides immitis in vitro and in vivo. Antimicrob Agents Chemother (1976) 1.16
Isolation and properties of viruses from poultry in Hong Kong which represent a new (sixth) distinct group of avian paramyxoviruses. J Gen Virol (1980) 1.15
Anti-human immunodeficiency virus drugs are ineffective against Pneumocystis carinii in vitro and in vivo. J Infect Dis (2001) 1.13
Location of neutralizing epitopes on the fusion protein of Newcastle disease virus strain Beaudette C. J Gen Virol (1989) 1.12
Cutaneous infection in man caused by Fusarium moniliforme. Sabouraudia (1977) 1.08
The genome of Pneumocystis carinii. FEMS Immunol Med Microbiol (1998) 1.06
Analyses of Pneumocystis fatty acids. J Protozool (1989) 1.04
Inhibitors of sterol biosynthesis and amphotericin B reduce the viability of pneumocystis carinii f. sp. carinii. Antimicrob Agents Chemother (2000) 1.04
Astrovirus-like particles associated with hepatitis in ducklings. Vet Rec (1984) 1.03
Pathogenicity of PMV-3/parakeet/Netherlands/449/75 for chickens. Avian Pathol (1982) 0.99
New nomenclature for the genus Pneumocystis. J Eukaryot Microbiol (2001) 0.99
Assays for testing Pneumocystis carinii viability. J Protozool (1992) 0.97
Anti-Pseudomonas aeruginosa activity of an intravenous human IgG preparation in burned mice. J Trauma (1983) 0.95
Predisposing factors in Pneumocystis carinii pneumonia: effects of tetracycline, protein malnutrition, and corticosteroids on hosts. Infect Immun (1984) 0.95
Discrimination of rat-derived Pneumocystis carinii f. sp. Carinii and Pneumocystis carinii f. sp. Ratti using the polymerase chain reaction. Mol Cell Probes (1999) 0.95
Antigenic differences associated with genetically distinct Pneumocystis carinii from rats. Infect Immun (1996) 0.94
Antigenic and genetic characterisation of Newcastle disease viruses isolated from outbreaks in domestic fowl and turkeys in Great Britain during 1997. Vet Rec (1999) 0.93
Avian infectious bronchitis virus structural polypeptides: effect of different conditions of disruption and comparison of different strains and isolates. Arch Virol (1980) 0.93
Lysozyme-enhanced killing of Candida albicans and Coccidioides immitis by amphoteracin B. Sabouraudia (1974) 0.93
Analysis of Pneumocystis carinii cyst wall. II. Sugar composition. J Protozool (1990) 0.93
Latent Pneumocystis carinii infection in commercial rat colonies: comparison of inductive immunosuppressants plus histopathology, PCR, and serology as detection methods. J Clin Microbiol (1999) 0.92
Uniform susceptibility of various strains of Coccidioides immitis to amphotericin B. Antimicrob Agents Chemother (1977) 0.92
Pneumocystis taxonomy and nomenclature: an update. J Eukaryot Microbiol (1998) 0.91
Lectins as probes to Pneumocystis carinii surface glycocomplexes. J Protozool (1989) 0.90
Rapid pathotyping of Newcastle disease virus (NDV) using fluorogenic probes in a PCR assay. Vet Microbiol (2001) 0.90
Paramyxovirus type 1 infections of racing pigeons: 1 characterisation of isolated viruses. Vet Rec (1984) 0.90
Standardization of an in vitro drug screening assay by use of cryopreserved and characterized Pneumocystis carinii populations. J Eukaryot Microbiol (2001) 0.89
Monoclonal antibody-mediated protection and neutralization of motility in experimental Proteus mirabilis infection. Infect Immun (1989) 0.89
Cultivation of Pneumocystis carinii in lung-derived cell lines. J Infect Dis (1984) 0.89
Pseudomonas hyperimmune globulin passive immunotherapy for pulmonary exacerbations in cystic fibrosis. Pediatr Pulmonol (1990) 0.88
Use of semiquantitative PCR to assess onset and treatment of Pneumocystis carinii infection in rat model. J Clin Microbiol (1995) 0.88
Analysis of Pneumocystis carinii cyst wall. I. Evidence for an outer surface membrane. J Protozool (1990) 0.88
Techniques for examining Pneumocystis carinii in fresh specimens. J Clin Microbiol (1986) 0.87
Treatment of experimental Pseudomonas aeruginosa pneumonia with a human IgM monoclonal antibody. J Infect Dis (1989) 0.87
Effect of pH on the growth and cytopathogenicity of avian infectious bronchitis virus in chick kidney cells. Arch Virol (1975) 0.86
The fungal nature of Pneumocystis. J Med Vet Mycol (1992) 0.86
Integrative research review of risk behaviors among adolescents in rural, suburban, and urban areas. J Adolesc Health (1999) 0.86
Early acquisition of Pneumocystis carinii in neonatal rats using targeted PCR and oral swabs. J Eukaryot Microbiol (2001) 0.86
Sequence from ribosomal RNA of Pneumocystis carinii compared to those of four fungi suggests an ascomycetous affinity. J Protozool (1989) 0.85
Antigenic and structural relationships between avian paramyxoviruses isolated from ducks in Hong Kong and Mississippi, U.S.A. J Gen Virol (1979) 0.84
Molecular characterization of a novel repetitive element from Pneumocystis carinii from rats. J Clin Microbiol (1993) 0.84
Characterization of viruses from doves representing a new serotype of avian paramyxoviruses. Arch Virol (1981) 0.83
In vitro and in vivo effects of quinupristin-dalfopristin against Pneumocystis carinii. Antimicrob Agents Chemother (2001) 0.83
Further characterisation of a virus associated with turkey rhinotracheitis. Vet Rec (1986) 0.83
Ultrastructural observations on life cycle stages of Pneumocystis carinii. J Protozool (1989) 0.82
Characterisation of avian paramyxoviruses of serotype PMV-3 isolated from commercial turkeys in Great Britain. Avian Pathol (1984) 0.82
Antigenic differences among genetically distinct types of rat-derived Pneumocystis carinii. J Eukaryot Microbiol (1995) 0.82
Properties of a newly isolated, serologically distinct avian paramyxovirus. Arch Virol (1979) 0.82
Development of a real-time reverse-transcription PCR for the detection and simultaneous pathotyping of Newcastle disease virus isolates using a novel probe. Arch Virol (2009) 0.82
Stability of four genetic loci in Pneumocystis carinii sp. f. carinii. J Eukaryot Microbiol (1996) 0.82
Immunobiology of Pneumocystis carinii. Pathol Immunopathol Res (1989) 0.82
Use of monoclonal antibodies in the characterisation of avian paramyxovirus type 1 (Newcastle disease virus) isolates submitted to an international reference laboratory. Avian Pathol (1987) 0.81
Comparative in vivo activity between intravenous immune globulin prepared by reduction and alkylation or by low pH. J Infect Dis (1985) 0.81
Characterization of paramyxoviruses isolated from penguins in Antarctica and sub-Antarctica during 1976-1979. Arch Virol (1989) 0.81
Heterogeneity of infectious bronchitis virus grown in eggs. Arch Virol (1976) 0.81
Identification of paramyxoviruses isolated from birds dying in quarantine in Great Britain during 1980 to 1981. Vet Rec (1982) 0.81
Preparation and characterization of a nontoxic polysaccharide-protein conjugate that induces active immunity and passively protective antibody against Pseudomonas aeruginosa immunotype 1 in mice. Infect Immun (1984) 0.81
Antibodies to TRT in chickens with swollen head syndrome. Vet Rec (1987) 0.80
Experimental infection of turkeys, chickens, ducks, geese, guinea fowl, pheasants and pigeons with turkey rhinotracheitis virus. Vet Rec (1988) 0.80
Paragonimus westermani: a cause of cavitary lung disease in an Indochinese refugee. South Med J (1981) 0.80
The polypeptide composition of isolated surface projections of avian infectious bronchitis virus. J Gen Virol (1980) 0.80
Use of fluorescent probes to investigate the metabolic state of Pneumocystis carinii mitochondria. J Eukaryot Microbiol (1995) 0.80
Putative transmissive form of Pneumocystis carinii f. sp. carinii. J Eukaryot Microbiol (2001) 0.79
Coinfection of rats with genetically diverse forms of Pneumocystis carinii demonstrated by P. carinii inosine monophosphate dehydrogenase gene polymorphism. J Eukaryot Microbiol (1995) 0.79
Experimental assessment of the pathogenicity of the Newcastle disease viruses from outbreaks in Great Britain in 1997 for chickens and turkeys, and the protection afforded by vaccination. Avian Pathol (1999) 0.79
Interactions of two Pneumocystis carinii populations within rat lungs. J Eukaryot Microbiol (1999) 0.79
Enzyme replacement for lactose malabsorption using a beta-D-galactosidase. J Clin Gastroenterol (1989) 0.79
Serology and P carinii. Chest (1987) 0.79